revatishintel

  According to a new report from Intel Market Research , Global Hydroxycarbamide Market was valued at US$ 226 million in 2024 and is projected to reach US$ 338 million by 2032, growing at a steady CAGR of 6.1% during the forecast period (2025–2032). Download FREE Sample Report : https://www.intelmarketresearch.com/download-free-sample/12850/hydroxycarbamide-market This positive trajectory is primarily supported by the rising global burden of sickle cell disease, strategic expansions in oncology applications, and increased acceptance of low-cost essential medications. What is Hydroxycarbamide? Hydroxycarbamide , commonly known as hydroxyurea, is a foundational antineoplastic medication that inhibits DNA synthesis by targeting ribonucleotide reductase. The drug serves as a cornerstone therapy for multiple hematological conditions, most notably Sickle Cell Disease (SCD) where it significantly reduces the frequency of vaso-occlusive crises and the need for blood transfusions. Hydroxyc...